This post has been archived and contains information that may be out of date.
CHA has submitted comments on the Food and Drug Administration’s (FDA) revised draft guidance on clinical decision support (CDS) software, as part of the agency’s ongoing efforts to implement Section 3060(a) of the 21st Century Cures Act.
This content is restricted to members.
